Yves Wyckmans is Senior Director Business Development, part of the corporate business development team of Janssen, which is the pharmaceutical business of Johnson and Johnson.

He leads the transaction and negotiation teams for business development opportunities including licenses and M&A for the last 6 years. Over the years, he sat on numerous steering committees with a broad array of companies with whom Janssen has major co-developments, partnerships and alliances across Janssen’s entire portfolio.

He has over 20 years of broad pharma experience and lived and worked in both US and Europe. He led full development projects until approvals worldwide and as a regional strategic marking leader, he also led the launch and commercial strategy teams in the EMEA region.

Yves’ focus area is currently on the cardio/pulmonary field supporting that therapeutic area within Janssen. Yves lives and works out of Basel, Switzerland.